{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:39:11Z","timestamp":1787002751916,"version":"build-2736575974"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009881","name":"Juvenile Diabetes Research Foundation Canada","doi-asserted-by":"publisher","award":["5-CDA-2020-945-A-N"],"award-info":[{"award-number":["5-CDA-2020-945-A-N"]}],"id":[{"id":"10.13039\/100009881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["498342"],"award-info":[{"award-number":["498342"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canada Research Chair in Cell Therapies for Diabetes Alberta Diabetes Foundation Scholarship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Islet transplantation (ITx) has demonstrated that cellular therapies can improve glycemic control in patients with type 1 diabetes. However, cell death in the acute post-transplant period accounts for the loss of up to 70% of the islets, resulting in the requirement of multiple donors per recipient to achieve normoglycemia. Several studies have targeted apoptosis prevention after ITx; herein, our study explores a novel approach by modulating RIPK1-associated stress pathways using Necrostatin-1 (Nec-1) to enhance human islet survival, engraftment, and function post-transplant. Nec-1 treatment for 24\u2009h prior to transplant significantly reduced the expression of RIPK1 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0021) and RIPK3 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0042), resulting in decreased cell death (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001) and necroptosis (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001), measured as TUNEL\n                    <jats:sup>+<\/jats:sup>\n                    and pMLKL\n                    <jats:sup>+<\/jats:sup>\n                    cells, respectively, without affecting basal respiration or insulin secretion in human islets. Nec-1 treatment pre-transplant drastically reduced cytokine (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0083), NF\u03baB (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0179), TGF\u03b2 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0015) and TNF family (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0010) signaling pathways at the transcriptional level compared to control. These results correlated with increased diabetes reversal (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0200) and decreased reversal time (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0011) in the Nec-1-treated group compared to untreated controls. The success of Nec-1 treatment in this study showcases that short-term modulation of RIPK1-associated stress pathways promotes early human marginal mass engraftment post-ITx. In the clinical context, improvement of marginal mass islet function could enable single-donor islet infusion and could aid in future \u00df-cell replacement therapies, making ITx available to a broader population of individuals living with diabetes.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08728-8","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:07:27Z","timestamp":1775653647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["RIP kinase inhibition with Necrostatin-1 improves human marginal mass islet graft survival and function for the management of type 1 diabetes"],"prefix":"10.1038","volume":"17","author":[{"given":"Saloni","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1976-6298","authenticated-orcid":false,"given":"Nerea","family":"Cuesta-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6772-9062","authenticated-orcid":false,"given":"Joy","family":"Paramor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Polishevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4709-0723","authenticated-orcid":false,"given":"Karen","family":"Seeberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9175-6865","authenticated-orcid":false,"given":"Jessica","family":"Worton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6256-7692","authenticated-orcid":false,"given":"Purushothaman","family":"Kuppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2227-4446","authenticated-orcid":false,"given":"Andrew R.","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"8728_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S2213-8587(22)00114-0","volume":"10","author":"BA Marfil-Garza","year":"2022","unstructured":"Marfil-Garza BA, Imes S, Verhoeff K, Hefler J, Lam A, Dajani K, et al. Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada. Lancet Diab Endocrinol. 2022;10:519\u201332.","journal-title":"Lancet Diab Endocrinol"},{"key":"8728_CR2","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1001\/jama.293.7.830","volume":"293","author":"BJ Hering","year":"2005","unstructured":"Hering BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M, Sawada T, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA. 2005;293:830\u20135.","journal-title":"JAMA"},{"key":"8728_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.reth.2018.04.002","volume":"8","author":"I Fujita","year":"2018","unstructured":"Fujita I, Utoh R, Yamamoto M, Okano T, Yamato M. The liver surface as a favorable site for islet cell sheet transplantation in type 1 diabetes model mice. Regen Ther. 2018;8:65\u201372.","journal-title":"Regen Ther"},{"key":"8728_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1900\/RDS.2012.9.148","volume":"9","author":"KL Graham","year":"2012","unstructured":"Graham KL, Sutherland RM, Mannering SI, Zhao Y, Chee J, Krishnamurthy B, et al. Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease. Rev Diabet Stud. 2012;9:148\u201368.","journal-title":"Rev Diabet Stud"},{"key":"8728_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.639682","volume":"12","author":"A Carr\u00e9","year":"2021","unstructured":"Carr\u00e9 A, Mallone R. Making insulin and staying out of autoimmune trouble: the beta-cell conundrum. Front Immunol. 2021;12:639682.","journal-title":"Front Immunol"},{"key":"8728_CR6","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2337\/db05-1254","volume":"55","author":"JA Emamaullee","year":"2006","unstructured":"Emamaullee JA, Shapiro AM. Interventional strategies to prevent beta-cell apoptosis in islet transplantation. Diabetes. 2006;55:1907\u201314.","journal-title":"Diabetes"},{"key":"8728_CR7","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1097\/TP.0000000000001638","volume":"101","author":"AR Pepper","year":"2017","unstructured":"Pepper AR, Bruni A, Pawlick R, Wink J, Rafiei Y, Gala-Lopez B, et al. Engraftment site and effectiveness of the pan-caspase inhibitor F573 to improve engraftment in mouse and human islet transplantation in mice. Transplantation. 2017;101:2321\u20139.","journal-title":"Transplantation"},{"key":"8728_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.surg.2011.02.023","volume":"150","author":"M McCall","year":"2011","unstructured":"McCall M, Toso C, Emamaullee J, Pawlick R, Edgar R, Davis J, et al. The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in mice. Surgery. 2011;150:48\u201355.","journal-title":"Surgery"},{"key":"8728_CR9","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.2337\/db07-1452","volume":"57","author":"JA Emamaullee","year":"2008","unstructured":"Emamaullee JA, Davis J, Pawlick R, Toso C, Merani S, Cai SX, et al. The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice. Diabetes. 2008;57:1556\u201366.","journal-title":"Diabetes"},{"key":"8728_CR10","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.2337\/db06-1653","volume":"56","author":"JA Emamaullee","year":"2007","unstructured":"Emamaullee JA, Stanton L, Schur C, Shapiro AM. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation. Diabetes. 2007;56:1289\u201398.","journal-title":"Diabetes"},{"key":"8728_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1235-0","volume":"15","author":"YK Dhuriya","year":"2018","unstructured":"Dhuriya YK, Sharma D. Necroptosis: a regulated inflammatory mode of cell death. J Neuroinflammation. 2018;15:199.","journal-title":"J Neuroinflammation"},{"key":"8728_CR12","doi-asserted-by":"publisher","first-page":"12024","DOI":"10.1073\/pnas.1305538110","volume":"110","author":"A Linkermann","year":"2013","unstructured":"Linkermann A, Br\u00e4sen JH, Darding M, Jin MK, Sanz AB, Heller J-O, et al. Two independent pathways of regulated necrosis mediate ischemia\u2013reperfusion injury. Proc Natl Acad Sci USA. 2013;110:12024\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8728_CR13","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.1073\/pnas.1916427117","volume":"117","author":"MG Naito","year":"2020","unstructured":"Naito MG, Xu D, Amin P, Lee J, Wang H, Li W, et al. Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke. Proc Natl Acad Sci USA. 2020;117:4959\u201370.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8728_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105297","volume":"163","author":"L Cao","year":"2021","unstructured":"Cao L, Mu W. Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications. Pharm Res. 2021;163:105297.","journal-title":"Pharm Res"},{"key":"8728_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.176","volume":"3","author":"N Takahashi","year":"2012","unstructured":"Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W, DuHadaway JB, et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 2012;3:e437.","journal-title":"Cell Death Dis"},{"key":"8728_CR16","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.biopha.2017.09.063","volume":"95","author":"F Geng","year":"2017","unstructured":"Geng F, Yin H, Li Z, Li Q, He C, Wang Z, et al. Quantitative analysis of necrostatin-1, a necroptosis inhibitor by LC-MS\/MS and the study of its pharmacokinetics and bioavailability. Biomed Pharmacother. 2017;95:1479\u201385.","journal-title":"Biomed Pharmacother"},{"key":"8728_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nm1196","volume":"11","author":"AJ Muller","year":"2005","unstructured":"Muller AJ, DuHadaway JB, Donover PS, Sutanto-Ward E, Prendergast GC. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med. 2005;11:312\u20139.","journal-title":"Nat Med"},{"key":"8728_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00262-014-1549-4","volume":"63","author":"GC Prendergast","year":"2014","unstructured":"Prendergast GC, Smith C, Thomas S, Mandik-Nayak L, Laury-Kleintop L, Metz R, et al. Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer. Cancer Immunol Immunother. 2014;63:721\u201335.","journal-title":"Cancer Immunol Immunother"},{"key":"8728_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev A, Hitomi J, Germscheid M, Ch\u2019en IL, Korkina O, Teng X, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008;4:313\u201321.","journal-title":"Nat Chem Biol"},{"key":"8728_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79992-7","volume":"11","author":"S Miyazaki","year":"2021","unstructured":"Miyazaki S, Tashiro F, Tsuchiya T, Sasaki K, Miyazaki JI. Establishment of a long-term stable \u03b2-cell line and its application to analyze the effect of Gcg expression on insulin secretion. Sci Rep. 2021;11:477.","journal-title":"Sci Rep"},{"key":"8728_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/19382014.2016.1253652","volume":"8","author":"AR Pepper","year":"2016","unstructured":"Pepper AR, Bruni A, Pawlick RL, Gala-Lopez B, Rafiei Y, Wink J, et al. Long-term function and optimization of mouse and human islet transplantation in the subcutaneous device-less site. Islets. 2016;8:186\u201394.","journal-title":"Islets"},{"key":"8728_CR22","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/j.stemcr.2023.10.005","volume":"18","author":"N Cuesta-Gomez","year":"2023","unstructured":"Cuesta-Gomez N, Verhoeff K, Dadheech N, Pawlick R, Marfil-Garza B, Razavy H, et al. AT7867 promotes pancreatic progenitor differentiation of human iPSCs. Stem Cell Rep. 2023;18:2084\u201395.","journal-title":"Stem Cell Rep"},{"key":"8728_CR23","doi-asserted-by":"crossref","unstructured":"Szot GL, Koudria P, Bluestone JA. Transplantation of pancreatic islets into the kidney capsule of diabetic mice. J Vis Exp. 2007;19:404.","DOI":"10.3791\/404"},{"key":"8728_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1432-2277.2003.tb00361.x","volume":"16","author":"JR Lakey","year":"2003","unstructured":"Lakey JR, Burridge PW, Shapiro AM. Technical aspects of islet preparation and transplantation. Transpl Int. 2003;16:613\u201332.","journal-title":"Transpl Int"},{"key":"8728_CR25","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1073\/pnas.0611641104","volume":"104","author":"C Li","year":"2007","unstructured":"Li C, Chen P, Vaughan J, Lee KF, Vale W. Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasis. Proc Natl Acad Sci USA. 2007;104:4206\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8728_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.907036","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Wang S, Blokhuis B, Ruijtenbeek R, Garssen J, Redegeld F. Cell death triggers induce MLKL cleavage in multiple myeloma cells, which may promote cell death. Front Oncol. 2022;12:907036.","journal-title":"Front Oncol"},{"key":"8728_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41418-022-01061-5","volume":"30","author":"G Liccardi","year":"2023","unstructured":"Liccardi G, Annibaldi A. MLKL post-translational modifications: road signs to infection, inflammation and unknown destinations. Cell Death Differ. 2023;30:269\u201378.","journal-title":"Cell Death Differ"},{"key":"8728_CR28","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1128\/MCB.00774-12","volume":"32","author":"H Khalil","year":"2012","unstructured":"Khalil H, Peltzer N, Walicki J, Yang JY, Dubuis G, Gardiol N, et al. Caspase-3 protects stressed organs against cell death. Mol Cell Biol. 2012;32:4523\u201333.","journal-title":"Mol Cell Biol"},{"key":"8728_CR29","doi-asserted-by":"publisher","first-page":"e3003034","DOI":"10.1371\/journal.pbio.3003034","volume":"23","author":"G Samarasekera","year":"2025","unstructured":"Samarasekera G, Go NE, Choutka C, Xu J, Takemon Y, Chan J, et al. Caspase 3 and caspase 7 promote cytoprotective autophagy and the DNA damage response during non-lethal stress conditions in human breast cancer cells. PLoS Biol. 2025;23:e3003034.","journal-title":"PLoS Biol"},{"key":"8728_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.brainres.2011.01.041","volume":"1381","author":"DC Wagner","year":"2011","unstructured":"Wagner DC, Riegelsberger UM, Michalk S, H\u00e4rtig W, Kranz A, Boltze J. Cleaved caspase-3 expression after experimental stroke exhibits different phenotypes and is predominantly non-apoptotic. Brain Res. 2011;1381:237\u201342.","journal-title":"Brain Res"},{"key":"8728_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101681","volume":"69","author":"T Takiishi","year":"2023","unstructured":"Takiishi T, Xiao P, Franchimont M, Gilglioni EH, Arroba EN, Gurzov EN, et al. Inhibition of RIPK1 kinase does not affect diabetes development: \u03b2-Cells survive RIPK1 activation. Mol Metab. 2023;69:101681.","journal-title":"Mol Metab"},{"key":"8728_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101988","volume":"87","author":"\u00d6 Veli","year":"2024","unstructured":"Veli \u00d6, Kaya \u00d6, Varanda AB, Hildebrandt X, Xiao P, Estornes Y, et al. RIPK1 is dispensable for cell death regulation in \u03b2-cells during hyperglycemia. Mol Metab. 2024;87:101988.","journal-title":"Mol Metab"},{"key":"8728_CR33","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1038\/s44321-024-00074-6","volume":"16","author":"S Chiou","year":"2024","unstructured":"Chiou S, Al-Ani AH, Pan Y, Patel KM, Kong IY, Whitehead LW, et al. An immunohistochemical atlas of necroptotic pathway expression. EMBO Mol Med. 2024;16:1717\u201349.","journal-title":"EMBO Mol Med"},{"key":"8728_CR34","doi-asserted-by":"publisher","first-page":"e0227454","DOI":"10.1371\/journal.pone.0227454","volume":"15","author":"P Akara-Amornthum","year":"2020","unstructured":"Akara-Amornthum P, Lomphithak T, Choksi S, Tohtong R, Jitkaew S. Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-\u03b1 and chemotherapeutic gemcitabine-induced necroptosis. PLoS ONE. 2020;15:e0227454.","journal-title":"PLoS ONE"},{"key":"8728_CR35","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.neo.2021.03.003","volume":"23","author":"A Koch","year":"2021","unstructured":"Koch A, Jeiler B, Roedig J, van Wijk SJL, Dolgikh N, Fulda S. Smac mimetics and TRAIL cooperate to induce MLKL-dependent necroptosis in Burkitt\u2019s lymphoma cell lines. Neoplasia. 2021;23:539\u201350.","journal-title":"Neoplasia"},{"key":"8728_CR36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1593\/neo.11610","volume":"13","author":"B Laukens","year":"2011","unstructured":"Laukens B, Jennewein C, Schenk B, Vanlangenakker N, Schier A, Cristofanon S, et al. Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor \u03b1-induced necroptosis. Neoplasia. 2011;13:971\u20139.","journal-title":"Neoplasia"},{"key":"8728_CR37","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201947840","volume":"20","author":"T Douanne","year":"2019","unstructured":"Douanne T, Andr\u00e9-Gr\u00e9goire G, Trillet K, Thys A, Papin A, Feyeux M, et al. Pannexin-1 limits the production of proinflammatory cytokines during necroptosis. EMBO Rep. 2019;20:e47840.","journal-title":"EMBO Rep"},{"key":"8728_CR38","doi-asserted-by":"publisher","first-page":"11994","DOI":"10.1074\/jbc.RA118.007161","volume":"294","author":"J Chen","year":"2019","unstructured":"Chen J, Kuroki S, Someda M, Yonehara S. Interferon-\u03b3 induces the cell surface exposure of phosphatidylserine by activating the protein MLKL in the absence of caspase-8 activity. J Biol Chem. 2019;294:11994\u20132006.","journal-title":"J Biol Chem"},{"key":"8728_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1210\/er.2018-00154","volume":"40","author":"MR Rickels","year":"2019","unstructured":"Rickels MR, Robertson RP. Pancreatic islet transplantation in humans: recent progress and future directions. Endocr Rev. 2019;40:631\u201368.","journal-title":"Endocr Rev"},{"key":"8728_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1006376","volume":"13","author":"S Dini\u0107","year":"2022","unstructured":"Dini\u0107 S, Aramba\u0161i\u0107 Jovanovi\u0107 J, Uskokovi\u0107 A, Mihailovi\u0107 M, Grdovi\u0107 N, Toli\u0107 A, et al. Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management. Front Endocrinol. 2022;13:1006376.","journal-title":"Front Endocrinol"},{"key":"8728_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/imr.12550","volume":"277","author":"V Kondylis","year":"2017","unstructured":"Kondylis V, Kumari S, Vlantis K, Pasparakis M. The interplay of IKK, NF-\u03baB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation. Immunol Rev. 2017;277:113\u201327.","journal-title":"Immunol Rev"},{"key":"8728_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms19072043","volume":"19","author":"Z Mao","year":"2018","unstructured":"Mao Z, Zhang W. Role of mTOR in glucose and lipid metabolism. Int J Mol Sci. 2018;19:1\u201314.","journal-title":"Int J Mol Sci"},{"key":"8728_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/cdd.2012.151","volume":"20","author":"P Vandenabeele","year":"2013","unstructured":"Vandenabeele P, Grootjans S, Callewaert N, Takahashi N. Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models. Cell Death Differ. 2013;20:185\u20137.","journal-title":"Cell Death Differ"},{"key":"8728_CR44","doi-asserted-by":"publisher","first-page":"e23209","DOI":"10.1371\/journal.pone.0023209","volume":"6","author":"Y Cho","year":"2011","unstructured":"Cho Y, McQuade T, Zhang H, Zhang J, Chan FK. RIP1-dependent and independent effects of necrostatin-1 in necrosis and T cell activation. PLoS ONE. 2011;6:e23209.","journal-title":"PLoS ONE"},{"key":"8728_CR45","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1016\/j.febslet.2011.08.028","volume":"585","author":"Y Tamura","year":"2011","unstructured":"Tamura Y, Chiba Y, Tanioka T, Shimizu N, Shinozaki S, Yamada M, et al. NO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic \u03b2-cells. FEBS Lett. 2011;585:3058\u201364.","journal-title":"FEBS Lett"},{"key":"8728_CR46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12031-015-0609-3","volume":"57","author":"S Nikseresht","year":"2015","unstructured":"Nikseresht S, Khodagholi F, Nategh M, Dargahi L. RIP1 inhibition rescues from LPS-induced RIP3-mediated programmed cell death, distributed energy metabolism and spatial memory impairment. J Mol Neurosci. 2015;57:219\u201330.","journal-title":"J Mol Neurosci"},{"key":"8728_CR47","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s11064-014-1510-0","volume":"40","author":"X Su","year":"2015","unstructured":"Su X, Wang H, Kang D, Zhu J, Sun Q, Li T, et al. Necrostatin-1 ameliorates intracerebral hemorrhage-induced brain injury in mice through inhibiting RIP1\/RIP3 pathway. Neurochem Res. 2015;40:643\u201350.","journal-title":"Neurochem Res"},{"key":"8728_CR48","doi-asserted-by":"crossref","unstructured":"Yuk H, Abdullah M, Kim DH, Lee H, Lee SJ. Necrostatin-1 prevents ferroptosis in a RIPK1- and IDO-independent manner in hepatocellular carcinoma. Antioxidants. 2021;10:1347\u201361.","DOI":"10.3390\/antiox10091347"},{"key":"8728_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00125-018-4750-8","volume":"62","author":"KA Leslie","year":"2019","unstructured":"Leslie KA, Russell MA, Taniguchi K, Richardson SJ, Morgan NG. The transcription factor STAT6 plays a critical role in promoting beta cell viability and is depleted in islets of individuals with type 1 diabetes. Diabetologia. 2019;62:87\u201398.","journal-title":"Diabetologia"},{"key":"8728_CR50","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41418-019-0344-3","volume":"27","author":"Q Weng","year":"2020","unstructured":"Weng Q, Zhao M, Zheng J, Yang L, Xu Z, Zhang Z, et al. STAT3 dictates \u03b2-cell apoptosis by modulating PTEN in streptozocin-induced hyperglycemia. Cell Death Differ. 2020;27:130\u201345.","journal-title":"Cell Death Differ"},{"key":"8728_CR51","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1007\/s00125-012-2566-5","volume":"55","author":"ZC Feng","year":"2012","unstructured":"Feng ZC, Li J, Turco BA, Riopel M, Yee SP, Wang R. Critical role of c-Kit in beta cell function: increased insulin secretion and protection against diabetes in a mouse model. Diabetologia. 2012;55:2214\u201325.","journal-title":"Diabetologia"},{"key":"8728_CR52","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/1872214810666161020154905","volume":"10","author":"V Sidarala","year":"2017","unstructured":"Sidarala V, Kowluru A. The regulatory roles of mitogen-activated protein kinase (MAPK) Pathways in health and diabetes: lessons learned from the pancreatic \u03b2-cell. Recent Pat Endocr Metab Immune Drug Discov. 2017;10:76\u201384.","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"8728_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.320","volume":"6","author":"S Pfeiffer","year":"2015","unstructured":"Pfeiffer S, Prehn JH. The esoteric roles of Bcl-2 family proteins in glucose homeostasis and cell survival. Cell Death Dis. 2015;6:e1968.","journal-title":"Cell Death Dis"},{"key":"8728_CR54","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1182\/blood-2014-10-606988","volume":"127","author":"JV Almaden","year":"2016","unstructured":"Almaden JV, Liu YC, Yang E, Otero DC, Birnbaum H, Davis-Turak J, et al. B-cell survival and development controlled by the coordination of NF-\u03baB family members RelB and cRel. Blood. 2016;127:1276\u201386.","journal-title":"Blood"},{"key":"8728_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-024-00452-7","volume":"19","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Zhang L, Zhang K, Wu S, Wang C, Huang R, et al. PLAU promotes growth and attenuates cisplatin chemosensitivity in ARID1A-depleted non-small cell lung cancer through interaction with TM4SF1. Biol Direct. 2024;19:7.","journal-title":"Biol Direct"},{"key":"8728_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-203","volume":"12","author":"BA McCarthy","year":"2012","unstructured":"McCarthy BA, Yang L, Ding J, Ren M, King W, ElSalanty M, et al. NF-\u03baB2 mutation targets survival, proliferation and differentiation pathways in the pathogenesis of plasma cell tumors. BMC Cancer. 2012;12:203.","journal-title":"BMC Cancer"},{"key":"8728_CR57","first-page":"667.e1.-e10","volume":"28","author":"S Gupta","year":"2022","unstructured":"Gupta S, Gangenahalli G. Vascular cell adhesion molecule 1-mediated targeting of human hematopoietic stem cells to bone marrow is effective in conferring regeneration and survival in lethally irradiated mice. Transpl Cell Ther. 2022;28:667.e1.-e10.","journal-title":"Transpl Cell Ther"},{"key":"8728_CR58","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1128\/MCB.25.9.3620-3629.2005","volume":"25","author":"N Liadis","year":"2005","unstructured":"Liadis N, Murakami K, Eweida M, Elford AR, Sheu L, Gaisano HY, et al. Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus. Mol Cell Biol. 2005;25:3620\u20139.","journal-title":"Mol Cell Biol"},{"key":"8728_CR59","doi-asserted-by":"publisher","first-page":"e0237669","DOI":"10.1371\/journal.pone.0237669","volume":"15","author":"C Uhlemeyer","year":"2020","unstructured":"Uhlemeyer C, M\u00fcller N, Grie\u00df K, Wessel C, Schlegel C, Kuboth J, et al. ATM and P53 differentially regulate pancreatic beta cell survival in Ins1E cells. PLoS ONE. 2020;15:e0237669.","journal-title":"PLoS ONE"},{"key":"8728_CR60","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.4161\/auto.28789","volume":"10","author":"W Zhong","year":"2014","unstructured":"Zhong W, Zhu H, Sheng F, Tian Y, Zhou J, Chen Y, et al. Activation of the MAPK11\/12\/13\/14 (p38 MAPK) pathway regulates the transcription of autophagy genes in response to oxidative stress induced by a novel copper complex in HeLa cells. Autophagy. 2014;10:1285\u2013300.","journal-title":"Autophagy"},{"key":"8728_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2368-5","volume":"11","author":"X Ma","year":"2020","unstructured":"Ma X, Qiu Y, Sun Y, Zhu L, Zhao Y, Li T, et al. NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway. Cell Death Dis. 2020;11:174.","journal-title":"Cell Death Dis"},{"key":"8728_CR62","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3389\/fimmu.2014.00253","volume":"5","author":"P Chatterjee","year":"2014","unstructured":"Chatterjee P, Chiasson VL, Bounds KR, Mitchell BM. Regulation of the anti-inflammatory cytokines interleukin-4 and interleukin-10 during pregnancy. Front Immunol. 2014;5:253.","journal-title":"Front Immunol"},{"key":"8728_CR63","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1089\/104303402760372945","volume":"13","author":"B Ke","year":"2002","unstructured":"Ke B, Shen XD, Zhai Y, Gao F, Busuttil RW, Volk HD, et al. Heme oxygenase 1 mediates the immunomodulatory and antiapoptotic effects of interleukin 13 gene therapy in vivo and in vitro. Hum Gene Ther. 2002;13:1845\u201357.","journal-title":"Hum Gene Ther"},{"key":"8728_CR64","doi-asserted-by":"publisher","first-page":"5676","DOI":"10.1111\/bph.12991","volume":"172","author":"WL Cheng","year":"2015","unstructured":"Cheng WL, Wang PX, Wang T, Zhang Y, Du C, Li H, et al. Regulator of G-protein signalling 5 protects against atherosclerosis in apolipoprotein E-deficient mice. Br J Pharm. 2015;172:5676\u201389.","journal-title":"Br J Pharm"},{"key":"8728_CR65","doi-asserted-by":"publisher","first-page":"779","DOI":"10.21873\/anticanres.14009","volume":"40","author":"JS You","year":"2020","unstructured":"You JS, Lim H, Kim TH, Oh JS, Lee GJ, Seo YS, et al. 25-Hydroxycholesterol induces death receptor-mediated extrinsic and mitochondria-dependent intrinsic apoptosis in head and neck squamous cell carcinoma cells. Anticancer Res. 2020;40:779\u201388.","journal-title":"Anticancer Res"},{"key":"8728_CR66","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1158\/0008-5472.CAN-05-2479","volume":"66","author":"RI You","year":"2006","unstructured":"You RI, Chen MC, Wang HW, Chou YC, Lin CH, Hsieh SL. Inhibition of lymphotoxin-beta receptor-mediated cell death by survivin-DeltaEx3. Cancer Res. 2006;66:3051\u201361.","journal-title":"Cancer Res"},{"key":"8728_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn5732","volume":"8","author":"F Szymczak","year":"2022","unstructured":"Szymczak F, Alvelos MI, Mar\u00edn-Ca\u00f1as S, Castela \u00c2, Demine S, Colli ML, et al. Transcription and splicing regulation by NLRC5 shape the interferon response in human pancreatic \u03b2 cells. Sci Adv. 2022;8:eabn5732.","journal-title":"Sci Adv"},{"key":"8728_CR68","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/ni.1771","volume":"10","author":"T Kawagoe","year":"2009","unstructured":"Kawagoe T, Takeuchi O, Takabatake Y, Kato H, Isaka Y, Tsujimura T, et al. TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nat Immunol. 2009;10:965\u201372.","journal-title":"Nat Immunol"},{"key":"8728_CR69","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s12276-023-01028-7","volume":"55","author":"SK Seo","year":"2023","unstructured":"Seo SK, Kwon B. Immune regulation through tryptophan metabolism. Exp Mol Med. 2023;55:1371\u20139.","journal-title":"Exp Mol Med"},{"key":"8728_CR70","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1111\/ajt.17162","volume":"22","author":"PK Paul","year":"2022","unstructured":"Paul PK, Das R, Drow T, Nylen EA, de Souza AH, Wang Z, et al. Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression. Am J Transplant. 2022;22:2571\u201385.","journal-title":"Am J Transplant"},{"key":"8728_CR71","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/j.1600-6143.2010.03190.x","volume":"10","author":"H Dell\u00ea","year":"2010","unstructured":"Dell\u00ea H, Noronha IL. Induction of indoleamine 2,3-dioxygenase by gene delivery in allogeneic islets prolongs allograft survival. Am J Transplant. 2010;10:1918\u201324.","journal-title":"Am J Transplant"},{"key":"8728_CR72","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.2337\/db09-1560","volume":"59","author":"RB Jalili","year":"2010","unstructured":"Jalili RB, Forouzandeh F, Rezakhanlou AM, Hartwell R, Medina A, Warnock GL, et al. Local expression of indoleamine 2,3 dioxygenase in syngeneic fibroblasts significantly prolongs survival of an engineered three-dimensional islet allograft. Diabetes. 2010;59:2219\u201327.","journal-title":"Diabetes"},{"key":"8728_CR73","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.ajt.2025.03.008","volume":"25","author":"RPH Meier","year":"2025","unstructured":"Meier RPH, Ben Nasr M, Fife BT, Finger EB, Fiorina P, Luo X, et al. Best practices in islet transplantation in mice. Am J Transplant. 2025;25:1399\u2013409.","journal-title":"Am J Transplant"},{"key":"8728_CR74","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/tri.12919","volume":"30","author":"V Delaune","year":"2017","unstructured":"Delaune V, Berney T, Lacotte S, Toso C. Intraportal islet transplantation: the impact of the liver microenvironment. Transpl Int. 2017;30:227\u201338.","journal-title":"Transpl Int"},{"key":"8728_CR75","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41591-021-01645-7","volume":"28","author":"Y Du","year":"2022","unstructured":"Du Y, Liang Z, Wang S, Sun D, Wang X, Liew SY, et al. Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates. Nat Med. 2022;28:272\u201382.","journal-title":"Nat Med"},{"key":"8728_CR76","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/j.1600-6143.2011.03977.x","volume":"12","author":"MD Bellin","year":"2012","unstructured":"Bellin MD, Barton FB, Heitman A, Harmon JV, Kandaswamy R, Balamurugan AN, et al. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am J Transplant. 2012;12:1576\u201383.","journal-title":"Am J Transplant"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08728-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08728-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08728-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:02:52Z","timestamp":1779213772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08728-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8728"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08728-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"501"}}